Stock Analysts

Microsoft Takes Over Parature

Reportedly, the world’s largest software maker Microsoft Corp. ( MSFT ) has acquired customer service software firm, Parature for an undisclosed amount to strengthen its customer relationship management (CRM) product portfolio. […]

Stock Analysts

hhgregg Reports Preliminary Sales

Appliance and electronics retailer hhgregg, Inc. ( HGG ) announced weak preliminary sales for the third quarter of fiscal 2014 (ended Dec 31, 2013), final results of which are scheduled to be released on Jan 30. For the third quarter, the company expects net sales to decline approximately 11.6% year over year to $799.6 million, due to a decline of approximately 11.2% in comparable store sales […]

Upgrades

WESTERN GAS EP (WGP) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of WESTERN GAS EP (WGP) from NEUTRAL to OUTPERFORM on January 07, 2014, with a target price of $44.30. Western Gas Equity Partners, LP is formed to own, operate, acquire and develop midstream energy assets. Western Gas Equity Partners, LP is based in The Woodlands, Texas. […]

Upgrades

NEKTAR THERAP (NKTR) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of NEKTAR THERAP (NKTR) from NEUTRAL to OUTPERFORM on January 07, 2014, with a target price of $12.90. Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to meet unmet medical needs and improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain. […]

Upgrades

HORIZON PHARMA (HZNP) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of HORIZON PHARMA (HZNP) from NEUTRAL to OUTPERFORM on January 07, 2014, with a target price of $8.80. Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases […]

Upgrades

CARDIOVASCLR SY (CSII) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of CARDIOVASCLR SY (CSII) from NEUTRAL to OUTPERFORM on January 07, 2014, with a target price of $34.80. Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease […]

Upgrades

COHERENT INC (COHR) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of COHERENT INC (COHR) from NEUTRAL to OUTPERFORM on January 07, 2014, with a target price of $75.30. COHERENT INC. designs, manufactures, and supplies electro-optical systems and medical instruments utilizing laser, precision optic and microelectronic technologies. […]

Downgrades

AVIV REIT INC (AVIV) Downgraded by Zacks to UNDERPERFORM

Zacks Investment Research downgraded shares of AVIV REIT INC (AVIV) from NEUTRAL to UNDERPERFORM on January 07, 2014, with a target price of $22.10. Aviv REIT, Inc. is engaged in the ownership and triple-net leasing of post-acute and long-term care skilled nursing facilities primarily in the United States […]